We are live on ! Find out more
TD Asset Management

TD Asset Management Portfolio holdings

AUM $115B
1-Year Est. Return 41.58%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$109B
AUM Growth
-$10.2B
Cap. Flow
-$4.9B
Cap. Flow %
-4.48%
Top 10 Hldgs %
29.03%
Holding
1,546
New
53
Increased
403
Reduced
866
Closed
64

Sector Composition

Rank Sector Weight
1 Financials 19.47%
2 Technology 18.71%
3 Healthcare 9.11%
4 Consumer Discretionary 9.07%
5 Communication Services 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCLE
826
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
$4.92M ﹤0.01%
500,000
JBSS icon
827
John B. Sanfilippo & Son
JBSS
$996M
$4.91M ﹤0.01%
58,800
EIG icon
828
Employers Holdings
EIG
$912M
$4.89M ﹤0.01%
119,200
-11,200
-9% -$448K
ZNTL icon
829
Zentalis Pharmaceuticals
ZNTL
$352M
$4.89M ﹤0.01%
105,903
-11,730
-10% -$633K
LCAA
830
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
$4.88M ﹤0.01%
500,000
HAAC
831
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$4.87M ﹤0.01%
493,900
+159,300
+48% +$1.56M
LVS icon
832
Las Vegas Sands
LVS
$29.7B
$4.86M ﹤0.01%
125,116
-588
-0.5% -$24.4K
IDA icon
833
Idacorp
IDA
$8.29B
$4.84M ﹤0.01%
41,986
-6,208
-13% -$676K
HMN icon
834
Horace Mann Educators
HMN
$2.1B
$4.77M ﹤0.01%
114,050
-18,600
-14% -$746K
TXG icon
835
10x Genomics
TXG
$6.03B
$4.76M ﹤0.01%
62,533
+2,538
+4% +$222K
PRTA icon
836
Prothena Corp
PRTA
$444M
$4.72M ﹤0.01%
129,141
-34,076
-21% -$1.23M
VTRS icon
837
Viatris
VTRS
$20.6B
$4.67M ﹤0.01%
429,392
-214
-0% -$2.82K
CHRW icon
838
C.H. Robinson
CHRW
$17.9B
$4.59M ﹤0.01%
42,622
-353
-0.8% -$35.9K
COKE icon
839
Coca-Cola Consolidated
COKE
$12.3B
$4.59M ﹤0.01%
92,360
+20,360
+28% +$1.1M
IAG icon
840
IAMGOLD
IAG
$9.18B
$4.59M ﹤0.01%
1,320,481
-149,011
-10% -$447K
LNTH icon
841
Lantheus
LNTH
$6.61B
$4.57M ﹤0.01%
82,527
+6,293
+8% +$236K
FATE icon
842
Fate Therapeutics
FATE
$303M
$4.56M ﹤0.01%
117,580
+10,899
+10% +$422K
JBTM
843
JBT Marel
JBTM
$6.35B
$4.55M ﹤0.01%
38,414
-11,052
-22% -$1.41M
ONC
844
BeOne Medicines Ltd
ONC
$34B
$4.52M ﹤0.01%
23,965
-561
-2% -$119K
BABA icon
845
Alibaba
BABA
$308B
$4.5M ﹤0.01%
41,395
-6,039
-13% -$696K
PFSI icon
846
PennyMac Financial
PFSI
$3.94B
$4.49M ﹤0.01%
84,424
-5,558
-6% -$336K
OM icon
847
Outset Medical
OM
$94.9M
$4.45M ﹤0.01%
6,529
+411
+7% +$247K
BAH icon
848
Booz Allen Hamilton
BAH
$8.65B
$4.41M ﹤0.01%
50,234
-26,028
-34% -$2.14M
GH icon
849
Guardant Health
GH
$21.9B
$4.4M ﹤0.01%
66,442
+1,105
+2% +$75.6K
EOCW
850
DELISTED
Elliott Opportunity II Corp.
EOCW
$4.4M ﹤0.01%
450,000

Similar funds

TD Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, TD Asset Management held 1,546 positions worth $109B, down 8.5% from $119B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

TD Asset Management withdrew a net $4.9B in Q1 2022, closing 64 positions and reducing 866 holdings. Its most notable exit was Kirkland Lake Gold Ltd Ordinary, an estimated $61.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, TD Asset Management opened a new position in SPDR Gold Trust worth $251M.

  • TD Asset Management's largest Q1 2022 buy was SPDR Gold Trust: 1,391,625 shares worth $251M.
  • TD Asset Management added most to State Street Financial Select Sector SPDR ETF in Q1 2022, an estimated $217M increase.
  • TD Asset Management's biggest Q1 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.28B.
  • TD Asset Management fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $61.3M.
  • TD Asset Management's ten largest holdings make up 29% of its $109B portfolio in Q1 2022.
  • TD Asset Management opened 53 new positions and closed 64 in Q1 2022.
  • TD Asset Management's portfolio value fell 8.5% quarter-over-quarter to $109B.

Based on TD Asset Management's 13F filing for Q1 2022, filed 10 May 2022.